United Therapeutics | UTHR - Sales Revenues



United Therapeutics reported $798.6M in Sales Revenues for its fiscal quarter ending in June of 2025.


Sales Change Date
Amarin USD 72.74M 30.72M Jun/2025
Ardelyx USD 97.66M 18.47M Jun/2025
Baxter International USD 2.81B 180M Jun/2025
Bayer EUR 10.74B 3B Jun/2025
Biogen USD 2.6B 170M Jun/2025
BioMarin Pharmaceutical USD 825M 80M Jun/2025
Gilead Sciences USD 7.1B 430M Jun/2025
GlaxoSmithKline GBP 7.99B 470M Jun/2025
Halozyme Therapeutics USD 206M 59M Jun/2025
Insmed USD 107.4M 14.58M Jun/2025
Ionis Pharmaceuticals USD 452M 320M Jun/2025
J&J USD 23.74B 1.85B Jun/2025
Moderna USD 142M 34M Jun/2025
Pfizer USD 14.7B 980M Jun/2025
PTC Therapeutics USD 178.9M 11.1M Jun/2025
Regeneron Pharmaceuticals USD 3.68B 650M Jun/2025
Sarepta Therapeutics USD 611.09M 163.81M Jun/2025
Teva Pharmaceutical Industries USD 14.06B 0 Jun/2025
United Therapeutics USD 798.6M 4.2M Jun/2025
Vertex Pharmaceuticals USD 2.96B 190M Jun/2025